Navigation Links
Shire's New Product Portfolio Delivers Strong Quarterly Performance
Date:10/29/2008

-------- -------- -------- --------

CASH FLOWS FROM OPERATING

ACTIVITIES:

Net income/(loss) 11.8 34.7 61.4 (1,663.9)

Adjustments to reconcile net

income/(loss) to net cash provided

by operating activities:

Loss from discontinued operations 0.9 - 0.9 -

Depreciation and amortization 49.1 48.1 145.4 111.8

Amortization of deferred financing

charges 1.3 1.4 3.8 10.6

Interest on building financing

obligation 0.7 - 2.6 -

Impairment of intangible assets - - 90.4 -

Impairment of available of sale

securities 54.1 - 54.1 -

Share based compensation 16.2 11.7 52.0 34.1

In-process R&D charge 120.5 - 120.5 1,896.0

Gain on sale of product rights (4.0) (7.1) (20.7) (12.1)

Gain on sale of long-term assets 0.4 - (9.4) -

Movement in deferred taxes 6.8 (49.6) 24.2 (35.8)

Equity in earnings of equity

method investees (1.6) (0.5) (1.3) (1.7)

Minority Interest (1.3) - (1.3) -

Changes in operating assets and

liabilities, net of acquisitions:

(Increase)/decrease in accounts

receivable (12.3) 38.8 (40.7) (64.2)

Increase in sales deduction

accrual 1.4 0.4 36.9 19.3

Decrease/(increase) in inventory 29.2 (6.2) 39.6 (46.2)

(Increase)/decrease in prepayments

and other current assets (8.4) (8.6) 15.8 2.7

(Incre
'/>"/>

SOURCE Shire Plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Beckman Coulter Signs Agreements with Adventist Health; Broad Product Offering Enhances Delivery of Quality Patient Care
2. PEAK Surgical Introduces PlasmaBlade(TM) Product Line Extensions for Use in General Surgery
3. Lilly Announces Launch of Color Differentiation System for Humalog(R) and Humulin(R) U-100 Insulin Products in the United States
4. GenOdyssee Receives Broad Product Applications Protection in EU for Founding Natural Evolution Technology
5. Consumers Looking to Sustainable Food Production to Feed Global Population
6. Contour Products Introduces Groundbreaking Sleep Apnea, Respiratory and Ergonomic Body Comfort Pillows at Medtrade; Self-Explanatory Products Serve Customer Needs, Expand Retailers DME Offerings
7. Glycotex Reports First Patient Enrollment in Phase IIb Study of Lead Product Candidate GLYC-101 for Wound Healing
8. Sustainable Oils Names Scott Johnson as General Manager, Expands Management Team for Camelina Research and Production
9. Ventria Expands Lactoferrin Production
10. China Biologic Products Provides Preliminary Guidance for 2009 of Revenues of $90 to $100 Million and Net Income of $18 to 22 Million
11. Advanced Analytical Technologies, Inc. Expands Into New Office and Production Space

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... , SEATTLE, Nov. 20 /PRNewswire-FirstCall/ ...CTIC) announced today that the Ninth Circuit Court...nd ruled that CTI should be allowed to pursue all ...case back to the District Court for trial. CTI fi...er third-party reimbursement consultant for CTI,s ...
(Date:11/19/2009)... , SEATTLE, Nov. 19 O... unaudited financial results for the third quarter...ded September 30, 2009, Omeros reported a net loss...to a net loss of $7.4 million, or $2.54 per share,...ended September 30, 2009, the Company reported a n...
(Date:11/19/2009)... , MALVERN, Pa. and WALTHAM, Mass., Nov. 19... and Decision Resources find that the leading driv... in Europe is broad-spectrum activity against gram...variety of organisms that can cause nosocomial pne...hey look primarily for agents that provide appropr...
(Date:11/19/2009)... InSound is honored by latest ... Newark, CA (PRWEB) November 16, 2009...ldquo;invisible” hearing aid from InSound Me... New Award in the Health category.  &nbs...s designed to reside deep in the hearing canal for...
Breaking Biology Technology:Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 3
.... 8 RxElite, Inc. (OTC,Bulletin Board: RXEI), a d...generic prescription drug products, announced toda...agreement, it has voluntarily instructed all named... Registration Statement on,Form SB-2 (File No. 333...her advised. This release corrects and should repl...
... SRA footprint in human health services around the...Va., Jan. 8 As part of its overall,expansion in n...today,announced the appointment of Timothy J. Atki...President and Chief Financial Officer (CFO) of its...was formed in October 2007 to,expand SRA,s footpri...
...etts, January 8 Primera Biosystems,Inc., an emerg...ams in,infectious disease and oncology, announced ...B financing led by Abingworth and joined by Interw...ogy Development Corporation,(MTDC), MPM Capital, B...ated in the round., "Primera plans to use this fi...
Other Biology Technology:/CORRECTION//- RxElite Temporarily Suspends Sales Under Its Registration Statement 2SRA Names Timothy J. Atkin Senior Vice President of Global Health Business; Appoints Mike Toner Global Health Unit Chief Financial Officer 2SRA Names Timothy J. Atkin Senior Vice President of Global Health Business; Appoints Mike Toner Global Health Unit Chief Financial Officer 3Primera Biosystems Raises $21 Million in Series B Private Round 2Primera Biosystems Raises $21 Million in Series B Private Round 3
(Date:11/19/2009)...ofessor of paleontology in the McMicken College of...he University of Chicago publish their research in..."Epicontinental Seas Versus Open-Ocean Settings: T..., For many years, paleobiological researchers int...d on charting the many ups (evolutionary radiation...
(Date:11/19/2009)... Director,s T-R01 Award , Speedier Lab Testing Wi...frey, associate professor of pharmacology at Weill...rchers to win a prestigious NIH Director,s Transfo...Health. Dr. Jaffrey and his colleagues are develop...at may some day speed up lab testing by instantane...
(Date:11/19/2009)...ofessor in the Fischell Department of Bioengineeri...ence Research and Technology Review Day with a tis...and other types of tissue for implantation. , Fi...nted in an eight minute pitch by faculty members a..., held November 12 at the University of Maryland. ...
Breaking Biology News(10 mins):Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 2Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 3Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 4Weill Cornell science briefs: November 2009 2Weill Cornell science briefs: November 2009 3Weill Cornell science briefs: November 2009 4Weill Cornell science briefs: November 2009 5Bioreactor for bone tissue engineering wins professor venture fair 2Bioreactor for bone tissue engineering wins professor venture fair 3Kensey Nash Corporation Announces Its First Quarter Fiscal Year 2010 Earnings Release Date and Teleconference 5367 1Kensey Nash Corporation Announces Its First Quarter Fiscal Year 2010 Earnings Release Date and Teleconference 5367 2HPV Tied to Rare Head and Neck Cancer 59233 1HPV Tied to Rare Head and Neck Cancer 59233 2Authoritative Report on Home Health Care Experiences Released By Press Ganey 59229 1Authoritative Report on Home Health Care Experiences Released By Press Ganey 59229 2Authoritative Report on Home Health Care Experiences Released By Press Ganey 59229 3
...ESTON, Virginia, February 10 WCC Smart Search &am...search and match software, today,announced its par...iometrics,Operations and Support Services - Unrest...ogram twelve designated contractors will compete f...97 million to provide,biometric services and solut...
... economy isn,t just squeezing the middle class on ...study by the Wildlife Conservation Society (WCS) a...urprising correlation between "middle class" commu...iously, areas with both low and high socio-economi...Appearing in the latest edition of Current Biolog...
...real, February 10, 2009 The year 2009 marks the 1... of the Species " a seminal book that permeated c... February 12 also marks the bicentennial anniversa...ontral professors can comment on how the Father of...philosophy to psychology: , Darwin and biology ,...
Other Biology News:WCC Smart Search & Match to Support U.S. Army's BOSS-U Program 2Study says 'middle class' coral reef fish feel the economic squeeze 2Darwin's seminal impact on biology, anthropology, philosophy and psychology 2Darwin's seminal impact on biology, anthropology, philosophy and psychology 3Darwin's seminal impact on biology, anthropology, philosophy and psychology 4
Cryopreservation Service from AbD Serotec
propidium iodide *1.0 mg/mL solution in water* from Molecular Probes (Invitrogen)
ExcelGel DNA Analysis Kit from GE Healthcare, formerly Amersham Biosciences
MagCellect Rat CD4+ T Cell Isolation Kit from R&D Systems
Biology Products: